Review
doi: 10.1016/0009-9120(90)90119-f.
Enzymes used in predicting high risk to colon cancer
Affiliations
- PMID: 2174752
- DOI: 10.1016/0009-9120(90)90119-f
Item in Clipboard
Review
Enzymes used in predicting high risk to colon cancer
Clin Biochem.
1990 Oct.
Abstract
Attempts have been made to use enzyme assays primarily in tissue, to predict risk of colon cancer in high risk colon cancer families, and in patients with polyposis. Efforts have also been made to predict recurrence in surgically "cured" cancer patients. The use of thymidine kinase, ornithine decarboxylase, LDH isoenzymes, and other enzymes for these purposes will be reviewed.
Similar articles
-
An assessment of proliferative and enzyme activity in transitional mucosa adjacent to colonic cancer.Cancer. 1989 Sep 1;64(5):1061-6. doi: 10.1002/1097-0142(19890901)64:5<1061::aid-cncr2820640517>3.0.co;2-1. Cancer. 1989. PMID: 2758383
-
Ornithine decarboxylase as a biologic marker in familial colonic polyposis.N Engl J Med. 1984 Jul 12;311(2):80-3. doi: 10.1056/NEJM198407123110202. N Engl J Med. 1984. PMID: 6738598
-
How do we detect hereditary large bowel cancer? Biochemical diagnosis.Prog Clin Biol Res. 1983;115:123-9. Prog Clin Biol Res. 1983. PMID: 6856628 No abstract available.
-
Ornithine decarboxylase as a marker for colorectal polyps and cancer.Prog Clin Biol Res. 1988;279:227-39. Prog Clin Biol Res. 1988. PMID: 3054922 Review.
-
Modifications of ornithine decarboxylase induced by phosphatases.Adv Exp Med Biol. 1988;250:55-70. doi: 10.1007/978-1-4684-5637-0_6. Adv Exp Med Biol. 1988. PMID: 2855562 Review. No abstract available.
Cited by
-
The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.J Bioenerg Biomembr. 1997 Aug;29(4):315-30. doi: 10.1023/a:1022490512705. J Bioenerg Biomembr. 1997. PMID: 9387092 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
